ChestEye Quality
JSON twin: https://www.healthaidb.com/software/chesteye-quality.json
Company Name
Oxipit
Product URL
https://oxipit.ai/products/chesteye/
Company URL
https://oxipit.ai
Categories
Summary
ChestEye Quality is an AI-powered tool that assists radiologists by analyzing chest X-ray images and reports to identify potential discrepancies, enhancing diagnostic accuracy and patient outcomes.
Description
ChestEye Quality is an AI-driven double-reading medical imaging tool developed by Oxipit. It analyzes final radiologist reports and corresponding medical images in near-real-time to identify reporting errors and improve patient outcomes. The platform operates in both retrospective and prospective modes, providing comprehensive quality assurance for chest X-rays, musculoskeletal X-rays, mammography studies, and CT scans. It integrates seamlessly into existing radiology workflows, offering quick deployment and minimal technical involvement from the client side. The system is fully GDPR compliant, anonymizing all identifiable data and operating onsite. Additionally, it supports multiple languages, accommodating diverse healthcare environments. Built upon the ChestEye Imaging Suite, ChestEye Quality covers 75 of the most common radiological findings, addressing over 90% of pathologies encountered daily in medical institutions. This extensive coverage enables the detection of subtle secondary findings, such as small pulmonary nodules, facilitating earlier detection of conditions like lung cancer. By providing a 'second set of eyes,' ChestEye Quality acts as a safety net, assisting radiologists in real-time and improving diagnostic performance. The platform has been deployed in multiple medical institutions across Europe, demonstrating its effectiveness in enhancing diagnostic accuracy and patient outcomes. Oxipit, the company behind ChestEye Quality, was founded in 2019 and is headquartered in Vilnius, Lithuania. The company has expanded its global reach, with deployments in various countries, including Brazil, where it secured ANVISA clearance for the ChestEye AI Suite in 2023. Oxipit continues to collaborate with international partners to further enhance the capabilities and accessibility of its AI diagnostic products.
Api Available
yes
Certifications
- CE mark
- ANVISA (Brazil) clearance
Company Founding
2019
Company Offices
Compliance
Customers
Data Residency
EU-only, US/EU regions, BYO cloud region
Data Standards
Deployment Model
Features
- Automated chest X-ray double-reading for quality assurance
- Preliminary AI-generated reports for common findings
- Heatmaps and visualizations of detected findings
- Priority and triage flagging
- Comparison of radiologist reports with images to detect missed findings
- Retrospective similar-case search
- Case queue and management
- Analytics and dashboards for quality assurance metrics
- Support for multilingual reporting
- Integration with PACS and RIS workflows
Id
SW0738
Integration Partners
Integrations
- PACS
- RIS
- Sectra
- Alma Medical
- Blackford Analysis
Languages Supported
- English
- Lithuanian
- Spanish
- French
- German
- Italian
- Portuguese
- Dutch
- Russian
- Chinese
- Japanese
- Arabic
- Hindi
- Bengali
- Punjabi
- Javanese
- Korean
- Vietnamese
- Telugu
- Marathi
Last Updated
2025-10-11
License
Commercial
Market Segment
Optional Modules
- API interface
- Analytics module
- Web user interface
Os Platforms
Pricing Details
Contact vendor for pricing information.
Pricing Model
Subscription
Privacy Features
- BAA available
- Consent management
- Anonymization
- Data minimization
Product Code
SW0738
Product Name
ChestEye Quality
Ratings
Regions Available
Related Urls
Release Year
""
Security Features
- Encryption
- RBAC
- SSO/SAML
- Audit logs
- 2FA
- DLP
Specialties
Support Channels
System Requirements
Target Users
- Clinicians
- Radiologists
- Medical Institutions
- Healthcare Providers
- Patients
Training Options
Type
product
User Reviews
Version
1.0
Alternatives
See related products
Canonical JSON
{
"product_name": "ChestEye Quality",
"company_name": "Oxipit",
"product_url": "https://oxipit.ai/products/chesteye/",
"company_url": "https://oxipit.ai",
"related_urls": [
"https://healthairegister.com/radiology/products/oxipit-chesteye-quality"
],
"product_code": "SW0738",
"summary": "ChestEye Quality is an AI-powered tool that assists radiologists by analyzing chest X-ray images and reports to identify potential discrepancies, enhancing diagnostic accuracy and patient outcomes.",
"description": "ChestEye Quality is an AI-driven double-reading medical imaging tool developed by Oxipit. It analyzes final radiologist reports and corresponding medical images in near-real-time to identify reporting errors and improve patient outcomes. The platform operates in both retrospective and prospective modes, providing comprehensive quality assurance for chest X-rays, musculoskeletal X-rays, mammography studies, and CT scans. It integrates seamlessly into existing radiology workflows, offering quick deployment and minimal technical involvement from the client side. The system is fully GDPR compliant, anonymizing all identifiable data and operating onsite. Additionally, it supports multiple languages, accommodating diverse healthcare environments. Built upon the ChestEye Imaging Suite, ChestEye Quality covers 75 of the most common radiological findings, addressing over 90% of pathologies encountered daily in medical institutions. This extensive coverage enables the detection of subtle secondary findings, such as small pulmonary nodules, facilitating earlier detection of conditions like lung cancer. By providing a 'second set of eyes,' ChestEye Quality acts as a safety net, assisting radiologists in real-time and improving diagnostic performance. The platform has been deployed in multiple medical institutions across Europe, demonstrating its effectiveness in enhancing diagnostic accuracy and patient outcomes. Oxipit, the company behind ChestEye Quality, was founded in 2019 and is headquartered in Vilnius, Lithuania. The company has expanded its global reach, with deployments in various countries, including Brazil, where it secured ANVISA clearance for the ChestEye AI Suite in 2023. Oxipit continues to collaborate with international partners to further enhance the capabilities and accessibility of its AI diagnostic products.",
"categories": [
"clinical Care",
"diagnostic Support",
"quality & Safety",
"imaging Software",
"radiology",
"ai Clinical Documentation Integrity",
"clinical Decision Support",
"healthcare It",
"patient Safety",
"clinical Workflow Optimization",
"healthcare Technology",
"Clinical",
"Diagnostic",
"Quality Assurance",
"Medical Imaging",
"Radiology",
"Artificial Intelligence",
"Healthcare It",
"Patient Safety",
"Workflow Optimization",
"Medical Technology"
],
"market_segment": [
"Enterprise",
"SMB",
"Consumer"
],
"target_users": [
"Clinicians",
"Radiologists",
"Medical Institutions",
"Healthcare Providers",
"Patients"
],
"specialties": [
"Radiology",
"Pulmonology",
"Oncology",
"Orthopedics",
"Mammography",
"Cardiology",
"Emergency Medicine",
"Intensive Care",
"Primary Care",
"Teleradiology"
],
"regions_available": [
"Europe",
"Brazil",
"United States",
"Canada",
"Australia",
"Asia",
"Africa",
"South America",
"Middle East",
"Oceania"
],
"languages_supported": [
"English",
"Lithuanian",
"Spanish",
"French",
"German",
"Italian",
"Portuguese",
"Dutch",
"Russian",
"Chinese",
"Japanese",
"Arabic",
"Hindi",
"Bengali",
"Punjabi",
"Javanese",
"Korean",
"Vietnamese",
"Telugu",
"Marathi"
],
"pricing_model": "Subscription",
"pricing_details": "Contact vendor for pricing information.",
"license": "Commercial",
"company_offices": [
"Lithuania",
"United States",
"Brazil",
"Australia",
"Germany",
"United Kingdom",
"France",
"Spain",
"Italy",
"India"
],
"company_founding": "2019",
"deployment_model": [
"SaaS",
"on_prem",
"hybrid"
],
"os_platforms": [
"Web"
],
"features": [
"Automated chest X-ray double-reading for quality assurance",
"Preliminary AI-generated reports for common findings",
"Heatmaps and visualizations of detected findings",
"Priority and triage flagging",
"Comparison of radiologist reports with images to detect missed findings",
"Retrospective similar-case search",
"Case queue and management",
"Analytics and dashboards for quality assurance metrics",
"Support for multilingual reporting",
"Integration with PACS and RIS workflows"
],
"optional_modules": [
"API interface",
"Analytics module",
"Web user interface"
],
"integrations": [
"PACS",
"RIS",
"Sectra",
"Alma Medical",
"Blackford Analysis"
],
"data_standards": [
"DICOM",
"HL7 v2"
],
"api_available": "yes",
"system_requirements": "",
"compliance": [
"CE (medical device)"
],
"certifications": [
"CE mark",
"ANVISA (Brazil) clearance"
],
"security_features": [
"Encryption",
"RBAC",
"SSO/SAML",
"Audit logs",
"2FA",
"DLP"
],
"privacy_features": [
"BAA available",
"Consent management",
"Anonymization",
"Data minimization"
],
"data_residency": "EU-only, US/EU regions, BYO cloud region",
"customers": [],
"user_reviews": [],
"ratings": [],
"support_channels": [],
"training_options": [],
"release_year": "\"\"",
"integration_partners": [],
"id": "SW0738",
"slug": "chesteye-quality",
"type": "product",
"version": "1.0",
"last_updated": "2025-10-11",
"links_json": {
"self": "https://www.healthaidb.com/software/chesteye-quality.json"
}
}